WEX Pharmaceuticals Inc:企業の戦略的SWOT分析

◆英語タイトル:WEX Pharmaceuticals Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C15784
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

WEX Pharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

WEX Pharmaceuticals Inc (WEX), a subsidiary of CK Life Sciences Int’l., (Holdings) Inc., is a clinical stage biotechnology company that focuses on the discovery, development, manufacture and commercialization of drugs for pain management. The company develops a new class of non-opioid analgesics utilizing its proprietary platform technology TTX (Tetrodotoxin or TTX). TTX is a non-peptide neurotoxin, non-addictive alternative to opioids, and a sodium channel blocker. WEX’s clinical candidates include TEC-006 and TTX-CINP-201. TEC-006 is being studied for the treatment of moderate to severe cancer related pain and TTX-CINP-201 is being developed for moderate to severe neuropathic pain caused by chemotherapy in patients with cancer. WEX is headquartered in Vancouver, British Columbia, Canada.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
WEX Pharmaceuticals Inc – Key Facts
WEX Pharmaceuticals Inc – Key Employees
WEX Pharmaceuticals Inc – Key Employee Biographies
WEX Pharmaceuticals Inc – Major Products and Services
WEX Pharmaceuticals Inc – History
WEX Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
WEX Pharmaceuticals Inc – Business Description
WEX Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
WEX Pharmaceuticals Inc – Strengths
WEX Pharmaceuticals Inc – Weaknesses
WEX Pharmaceuticals Inc – Opportunities
WEX Pharmaceuticals Inc – Threats
WEX Pharmaceuticals Inc – Key Competitors
Section 3 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
WEX Pharmaceuticals Inc, Key Facts
WEX Pharmaceuticals Inc, Key Employees
WEX Pharmaceuticals Inc, Key Employee Biographies
WEX Pharmaceuticals Inc, Major Products and Services
WEX Pharmaceuticals Inc, History
WEX Pharmaceuticals Inc, Key Competitors

★海外企業調査レポート[WEX Pharmaceuticals Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Citigroup Inc:戦略・SWOT・企業財務分析
    Citigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Citigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hyundai Motor Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hyundai Motor Company Mergers a …
  • Tokai Pharmaceuticals Inc (TKAI):企業のM&A・提携動向(医療分野)
    Summary Tokai Pharmaceuticals Inc (Tokai Pharma) is a biopharmaceutical company that develops and commercializes therapies for the treatment of prostate cancer and other hormonally-driven diseases. The company’s lead drug candidate, galeterone, an oral small molecule drug candidate which is intended …
  • Ardelyx Inc (ARDX):企業財務及び戦略的SWOT分析
    Summary Ardelyx Inc (Ardelyx) is a clinical stage biopharmaceutical company that discovers, develops and commercializes small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. Its product portfolio comprises Tenapanor, RDX227675, RDX98940 and RDX013. The …
  • Xilinx, Inc.:企業の戦略・SWOT・財務情報
    Xilinx, Inc. - Strategy, SWOT and Corporate Finance Report Summary Xilinx, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • StarTek, Inc. (SRT):企業の財務及び戦略的SWOT分析
    Summary StarTek, Inc. (StarTek) is a business process outsourcing company that provides contact center and customer engagement solutions. Its service solutions utilize STARTEK tools and technologies and offers multi-channel interactions across voice, e-mail, chat, SMS text and social media. It deliv …
  • Theravasc Inc-製薬・医療分野:企業M&A・提携分析
    Summary Theravasc Inc (Theravasc) is a healthcare services provider that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product TV1001SR is a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases an …
  • Prysmian S.p.A (PRY):企業のM&A・提携動向(発電分野)
    Summary Prysmian S.p.A (Prysmian) is a supplier of high-technology cables and systems. It develops, designs, produces, supplies and installs a wide portfolio of cables for various applications. The company provides underground and submarine power transmission cables and systems, special cables for a …
  • Jazztel PLC (JAZ):企業概要、財務及び戦略的SWOT分析
    Summary Jazztel PLC (Jazztel) is a telecommunication service provider. The company provides telephone and broadband services to diverse customers. It offers broadband solutions for voice traffic, data, internet and mobile phone for the residential customers. Jazztel also provides telemarketing and c …
  • ETA Electric Industry Co., Ltd. (6891):企業の財務及び戦略的SWOT分析
    Summary ETA Electric Industry Co., Ltd. (ETA Electric) is an electrical equipment company that provides switching power supply manufacturing. The company offers power supply unit products such as LED drivers, peak load components, PFCs, output models, compact size models with connector interface, mo …
  • Kratos Defense and Security Solutions, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Kratos Defense and Security Sol …
  • Advance Residence Investment Corp.:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Advance Residence Investment Corp." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric …
  • Asia Paper Manufacturing Co., Ltd.:企業の戦略・SWOT・財務情報
    Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Rhein Petroleum GmbH(石油・ガス分野):企業M&A動向
    Summary Rhein Petroleum GmbH (RP) is an oil and natural gas company. The company explores and produces oil and natural gas in Central Europe. Its licensed areas of Oberrhein Graben and Bavaria include Northern Upper Rhine, Heidelberg Weinheim, Middle Upper Rhine, Swabia South, Mindelheim, Rieden and …
  • Eguana Technologies Inc. (EGT):企業のM&A・提携動向(発電分野)
    Summary Eguana Technologies Inc. (Eguana), formerly Sustainable Energy Technologies Ltd, is a power electronics company. It designs, manufactures and supplies designs and manufactures high performance power electronics for residential and commercial energy storage systems. It offers grid edge power …
  • Menicon Co Ltd (7780)-医療機器分野:企業M&A・提携分析
    Summary Menicon Co Ltd (Menicon) is a medical device company that manufactures, export, import and markets ophthalmic products. The company’s products include soft contact lens, hard contact lens, astigmatic contact lens and bifocal contact lenses, among others. It offers contact lens care products …
  • RBC Capital Markets:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' RBC Capital Markets Mergers and …
  • Portlogic Systems Inc. (PGSY):企業の財務及び戦略的SWOT分析
    Summary Portlogic Systems Inc. (Portlogic) is a mobile and internet software development company that provides licensing of portal software products and custom software programming services. The company’s offers portal software product such as online administration interface and provides functionali …
  • ENERGO-PRO a.s.:企業のM&A・提携動向(エネルギー分野)
    Summary ENERGO-PRO a.s. (ENERGO-PRO) is an independent power producing company. It is engaged in the generation, delivery and commercialization of electricity from renewable energy sources. ENERGO-PRO owns and operates its own hydro power plants. Its power plant portfolio includes Sandanska Bistrits …
  • Trillium Therapeutics Inc (TR):企業財務及び戦略的SWOT分析
    Trillium Therapeutics Inc (TR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆